NYSE:OGN

Organon & Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy OGN

*Your capital is at risk

$13.40

+0.0200 (+0.149%)

At Close: Jun 03, 2026

Organon & Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 66.14. In total, the insiders bought 2.51B and sold 116.23M OGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	66.14
● Buy	2.51B shares
● Sell	116.23M shares
70% Buy Activity Weak Negative Correlation
Sell Signal Low Confidence May 06, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 66.14. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 31, 2026 Sell	Common Stock F-InKind	Nisita Vittorio Head Of Global Business Svcs	Officer	1 578 Value: $9K
Mar 31, 2026 Buy	Restricted Stock Units A-Award	Holzbaur Lynette SVP And Corporate Controller	Officer	75 125 Value: $450.0K
Mar 31, 2026 Buy	Restricted Stock Units A-Award	Morrissey Joseph T. Jr. Interim CEO	CEO / President	333 889 Value: $2.00M
Mar 31, 2026 Buy	Common Stock M-Exempt	Morrissey Joseph T. Jr. Interim CEO	CEO / President	7 795 Value: $46.7K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Walsh Matthew M Chief Financial Officer	C-Suite Officer	21 546 Value: $129.1K
Mar 31, 2026 Buy	Restricted Stock Units A-Award	Walsh Matthew M Chief Financial Officer	C-Suite Officer	83 472 Value: $500.0K
Mar 31, 2026 Buy	Common Stock M-Exempt	Falcione Aaron Chief Human Resources Officer	Officer	6 732 Value: $40.3K
Mar 31, 2026 Buy	Common Stock M-Exempt	Falcione Aaron Chief Human Resources Officer	Officer	11 193 Value: $67.0K
Mar 31, 2026 Sell	Common Stock F-InKind	Weaver Kirke Gen. Counsel & Corp. Secy.	Officer	3 508 Value: $20.0K
Mar 31, 2026 Sell	Common Stock F-InKind	Karp Daniel Executive Vp, Corp. Dev.	Officer	2 105 Value: $12.0K
Mar 31, 2026 Buy	Common Stock M-Exempt	Karp Daniel Executive Vp, Corp. Dev.	Officer	11 338 Value: $67.9K
Mar 31, 2026 Sell	Common Stock F-InKind	Karp Daniel Executive Vp, Corp. Dev.	Officer	3 554 Value: $20.3K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Karp Daniel Executive Vp, Corp. Dev.	Officer	6 715 Value: $40.2K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Karp Daniel Executive Vp, Corp. Dev.	Officer	11 338 Value: $67.9K
Mar 31, 2026 Buy	Restricted Stock Units A-Award	Stahler Rachel A Chief Information Officer	Officer	183 639 Value: $1.10M
Mar 31, 2026 Buy	Restricted Stock Units A-Award	Drinane Juliana Papa Interim Head Of Mfg & Supply	Officer	125 208 Value: $750.0K
Mar 31, 2026 Buy	Common Stock M-Exempt	Drinane Juliana Papa Interim Head Of Mfg & Supply	Officer	10 073 Value: $60.3K
Mar 31, 2026 Sell	Common Stock F-InKind	Drinane Juliana Papa Interim Head Of Mfg & Supply	Officer	3 451 Value: $19.7K
Mar 31, 2026 Buy	Common Stock M-Exempt	Stahler Rachel A Chief Information Officer	Officer	12 312 Value: $73.7K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Stahler Rachel A Chief Information Officer	Officer	12 312 Value: $73.7K
Mar 31, 2026 Buy	Restricted Stock Units A-Award	Walsh Matthew M Chief Financial Officer	C-Suite Officer	321 368 Value: $1.92M
Mar 29, 2026 Buy	Restricted Stock Units M-Exempt	Walsh Matthew M Chief Financial Officer	C-Suite Officer	15 071 Value: $202.0K
Mar 29, 2026 Sell	Common Stock F-InKind	Walsh Matthew M Chief Financial Officer	C-Suite Officer	5 162 Value: $30.1K
Mar 29, 2026 Buy	Restricted Stock Units M-Exempt	Falcione Aaron Chief Human Resources Officer	Officer	8 422 Value: $112.9K
Mar 29, 2026 Sell	Common Stock F-InKind	Arjona Ferreira Juan Camilo Head Of R&d & Cmo	Officer	3 181 Value: $18.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ORGANON & CO.

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology pr...

Read Full Profile Here